NET MERCHANDISE SALES GREW 9.2% COMPARABLE NET MERCHANDISE SALES INCREASED 7.5% $1.02EARNINGS PER DILUTED SHARE PriceSmart, Inc. (“PriceSmart” or the “Company”) (NASDAQ: PSMT), operator of 56warehouse clubs in 12countries and oneU.S. territory, today announced results for the fiscal fourth quarter of 2025, which ended on August31, 2025. https://mma.prnewswire.com/media/1740875/PriceSmart_Inc_Logo.jpg Fourth Quarter Financial Results Total revenues for […]

(NasdaqGM:ARDX), Q3 2025 product revenue of $105.5 million reflects 15% year-over-year growth IBSRELA(R) Q3 revenue of $78.2 million reflects 92% year-over-year growth; IBSRELA guidance raised, 2025 revenue expected to be between $270-275 million XPHOZAH(R) Q3 revenue of $27.4 million, up 9% compared to Q2 2025 Company announces pipeline program for next-generation NHE3 inhibitor; Potential application

(NASDAQ:ARHS), BOSTON HEIGHTS, Ohio, Oct. 30, 2025 (GLOBE NEWSWIRE) — Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS), a growing lifestyle brand and omnichannel retailer of premium artisan-crafted home furnishings, will release its third quarter 2025 results on Thursday, November 6, 2025, before the stock market opens, followed by a conference call to review the

(NASDAQ:MPWR), Schaffhausen, Switzerland, Oct. 30, 2025 (GLOBE NEWSWIRE) — MPS reported its results after market close on October 30, 2025 and will host a question-and-answer webinar at 2:00 p.m. PT / 5:00 p.m. ET. The live event will be held via a Zoom webcast, which can be accessed at https://mpsic.zoom.us/j/95600837087. Q3 2025 Financial Summary (Unaudited)

(NASDAQ:MPWR), Schaffhausen, Switzerland, Oct. 30, 2025 (GLOBE NEWSWIRE) — Monolithic Power Systems, Inc. (“MPS”) (Nasdaq: MPWR), a fabless global company that provides high-performance, semiconductor-based power electronics solutions, today announced financial results for the quarter ended September 30, 2025. The financial results for the quarter ended September 30, 2025 were as follows: Revenue was $737.2 million

(NasdaqGM:LGND), JUPITER, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) — Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will participate in the following upcoming investor conferences: UBS Global Healthcare Conference (Palm Beach Gardens): Management will participate in one-on-one meetings on November 10, 2025. Stifel 2025

(NASDAQ:CACC), Southfield, Michigan, Oct. 30, 2025 (GLOBE NEWSWIRE) — Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) today announced consolidated net income of $108.2 million, or $9.43 per diluted share, for the three months ended September 30, 2025. Adjusted net income, a non-GAAP financial measure, for the

(NASDAQ:SGMO), RICHMOND, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the company has scheduled the release of its third quarter 2025 financial results before the market opens on Thursday, November 6, 2025. The company will hold a conference call at 8:30 a.m. Eastern on

(NasdaqGM:PRME), CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) — Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that it will host a virtual event on Wednesday, November 12, 2025, to discuss its liver disease franchise and strategy, with a focus on

(NASDAQ:ALHC), Reports Q3 revenue of $993.7 million, up 43.5% year-over-year Beats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit and adjusted EBITDA Has 100% of members in plans rated 4 stars or higher for second consecutive year in 2026, including two 5-star contracts in